Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2012        Go!    
 
 
November 20, Monday 2017 7:46 AM       

       HEADLINES: Attack on Mayor: Case charged for murder attempt                                              What are principles should be discussed, Kanam’s reply to Kodiyeri                                              CM calls on Mayor V K Prasanth                                              CPM activist attacked in Kattakada                                              Attack towards mayor deliberate, says Pinarayi                                              210 govt websites made public Aadhaar details: UIDAI                                              Modi reiterates importance of sanitation on World Toilet Day                                              NCW to summon Tharoor for his tweet on Miss World 2017                                              Twitter suspends verified Pak Defense handle for faking Indian picture                                              Mugabe sacked, ex-VP replaces as party leader                                              Imran to quit politics if SC disqualifies him                                              Dhawan, Rahul help India close Day 4 with lead                                              Ranji Trophy: Sanju Samson hits ton as Kerala close in on victory                                              Afghan thrashes Pak to win U19 Asia Cup                                              British rider Daniel Hegarty dies in crash at Motorcycle GP                                              ISL: FC Goa pip Chennaiyin FC in five-goal thriller                                              Kaumudi Facebook
       SCI&TECH Next Article: Clearing the myths about osteoporosis  
       Aspirin a day may keep liver cancer away
 
         Posted on :18:27:33 Oct 21, 2017
   
A A
       Last edited on:18:27:33 Oct 21, 2017
         Tags: Aspirin a day may keep liver cancer away
 

WASHINGTON DC: Taking aspirin daily can reduce the risk of liver cancer, a new study suggested.

The researchers found that everyday aspirin therapy could significantly associate with a reduced risk in hepatitis B related liver cancer.

Hepatitis B is a viral infection that attacks the liver. HBV can be contracted through contact with an infected person's blood or other bodily fluid, and the infection can either be acute or chronic.

It has been estimated that around estimated 240 million people worldwide have chronic HBV. The findings also show Africa and Asia as the highest prevalence of the virus.

Previous studies also show that daily aspirin therapy -- which is often prescribed to prevent cardiovascular disease -- may also prevent the development of cancer.

However, on another note clinical evidence is being lacked for the effectiveness of aspirin therapy in preventing HBV-related liver cancer.

Researcher Teng-Yu Lee from the Taichung Veterans General Hospital conducted a nationwide cohort study to determine if aspirin therapy could, indeed, reduce liver cancer risk.

"Liver cancer is the second leading cause of cancer death worldwide, and HBV is the most prevalent risk factor in our region," said Dr. Lee who's the lead author of the study.

"HBV-related liver cancer is therefore a major public health issue with a severe socioeconomic impact," he stated.

Dr. Lee stated that therapies which reduce the risk of liver cancer like, nucleos(t)ide analogue therapy, do not completely eliminate the risk. Adding, he also mentioned that most HBV carriers are not indicated for antiviral therapy, so another effective way of reducing liver cancer risk needs to be developed.

"Aspirin has been investigated to explore its chemopreventive effect in cancers that are related to chronic inflammation, particularly in the prevention of colorectal cancer. However, clinical evidence supporting the chemopreventive effect of aspirin therapy on liver cancer remains limited. Therefore, we conducted a large-scale cohort study to evaluate the association of aspirin therapy with HBV-related liver cancer," he noted.

Retrieving past medical records for the study, they screened records of 204,507 patients with chronic hepatitis B, and excluded patients with other forms of infectious hepatitis, from the National Health Insurance Research Database between the year 1998 and 2012.

The past findings showed that 1,553 patients who continuously received daily aspirin for at least 90 days were randomly matched 1:4 with 6,212 patients who had never received anti- platelet therapy by means of propensity scores consisting of baseline characteristics.

The researchers analyzed both cumulative incidents of and hazard ratios for HCC development after adjusting for competing mortality.

Cumulative incidence of liver cancer in the group treated with aspirin therapy was significantly lower than that in the untreated group in five years.

The researchers in their multivariate regression analysis found that aspirin therapy was independently associated with reduced liver cancer risk.

"For effectively preventing HBV-related liver cancer, the findings of this study may help hepatologists treat patients with chronic HBV infection in the future, particularly for those who are not indicated for antiviral therapy. We are pursuing prospective investigations for further confirming the findings," stated Dr. Lee.

The study presented at The Liver Meeting held by the American Association for the Study of Liver Diseases (AASLD).

A A
       SCI&TECH
Next Article: Clearing the myths about osteoporosis
 
 
SCI&TECH HEADLINES
Owning a dog may add years to your life  
'Textisms' actually add meaning to written words  
Sugar may heal wounds, says study  
Heart-stopping sex? It's rare  
Over 1.3 lakh Indians 'book ticket' to Mars  
China all set to make first contact with aliens  
Greenland Ice sheet could be losing mass, says study  
'Flying taxis' could be a thing by 2020  
When art comes to the rescue of depressed patients  
Here's a mechanism that can help you get rid of bad memories  
2017 ozone hole smallest since 1988: NASA  
Marijuana can dull the brain in some HIV patients  
We use lesser brainpower than thought  
You can soon delete 'sent messages' on WhatsApp  
There is a connection between nose and emotions  
75% of pet reptiles die within a year: Study  
Gamma rays will reach beyond limits of light: Researchers  
Suicide molecules may help combat cancer: Study  
Aspirin a day may keep liver cancer away  
Clearing the myths about osteoporosis  
Stress as unhealthy as junk food  
Planet Nine does exist in solar system: NASA  
Blame these hormones if your dog is getting aggressive  
Save big on Infinix Note 4, Hot 4 Pro during Flipkart's 'Big Diwali Sale'  
Even modest exposure to oil can harm coastal, marine birds  
 
Do you support reservation for all economically bacward people?
yes
 
no
 
no opinion
 
 
 
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]kaumudi.com
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy